EGFR and posterior cortical atrophy: However, clinical trials in PCa patients have shown limited efficacy of EGFR-targeted drugs (Canil et al. 2005, Hammarsten et al. 2007, Schlomm et al. 2007, Gravis et al. 2008, Nabhan et al. 2009).